Inflammasomes and its importance in viral infections

Immunologic Research

Volumn 64, Issue 5-6, 2016, Pages 1101-1117

  Shrivastava, Gaurav ^a   León Juárez, Moisés ^b   García Cordero, Julio ^a   Meza Sánchez, David Eduardo ^a   Cedillo Barrón, Leticia ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

Author keywords

Inflammasome; NLRP3; NOD like receptor (NLR); Pyroptosis; Viral infection

Indexed keywords

ADAPTOR PROTEIN; AIM2 PROTEIN; APOPTOSIS ASSOCIATED SPECK LIKE PROTEIN CONTAINING CASPASE RECRUITMENT DOMAIN PROTEIN; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; NLRC5 PROTEIN; NLRX1 PROTEIN; NUCLEAR PROTEIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PROCASPASE 1; REGULATOR PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

CELL DAMAGE; CELL DEATH; CYTOKINE RELEASE; DISEASE COURSE; DNA VIRUS; DNA VIRUS INFECTION; ENZYME ACTIVATION; ENZYME INHIBITION; GENE; GENE ACTIVATION; GENE EXPRESSION; HOST CELL; HUMAN; IMMUNE EVASION; IMMUNE GENE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; INFLAMMATORY CELL; LYMPHOCYTE MIGRATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PYROPTOSIS; REGULATORY MECHANISM; REVIEW; RNA VIRUS; RNA VIRUS INFECTION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; ANIMAL; IMMUNOLOGY; INFLAMMATION; METABOLISM; VIROLOGY; VIRUS INFECTION;

ANIMALS; CASPASE 1; HUMANS; IMMUNE EVASION; INFLAMMASOMES; INFLAMMATION; INTERLEUKIN-18; INTERLEUKIN-1BETA; PYROPTOSIS; VIRULENCE FACTORS; VIRUS DISEASES; VIRUS REPLICATION;

EID: 84989896434     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-016-8873-z     Document Type: Review

References (148)

1. Medzhitov R, Janeway CA Jr. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol. 1997;9(1):4–9.
2. Medzhitov R, Janeway CA Jr. Decoding the patterns of self and nonself by the innate immune system. Science (80-). 2002;296(5566):298–300. doi:10.1126/science.1068883.
3. Wilkins C, Gale M. Recognition of viruses by cytoplasmic sensors. Curr Opin Immunol. 2010;22(1):41–7. doi:10.1016/j.coi.2009.12.003.
4. Pothlichet J, Meunier I, Davis BK, et al. Type I IFN triggers RIG-I/TLR3/NLRP3-dependent inflammasome activation in influenza A virus infected cells. PLoS Pathog. 2013;9(4):e1003256. doi:10.1371/journal.ppat.1003256.
5. Lawrence TM, Hudacek AW, de Zoete MR, Flavell RA, Schnell MJ. Rabies virus is recognized by the NLRP3 inflammasome and activates interleukin-1β release in murine dendritic cells. J Virol. 2013;87(10):5848–57. doi:10.1128/JVI.00203-13.
6. Subramanian N, Natarajan K, Clatworthy MR, Wang Z, Germain RN. The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation. Cell. 2013;153(2):348–61. doi:10.1016/j.cell.2013.02.054.
7. Park S, Juliana C, Hong S, et al. The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity. J Immunol. 2013;191(8):4358–66. doi:10.4049/jimmunol.1301170.
8. Cai X, Chen J, Xu H, et al. Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell. 2014;156(6):1207–22. doi:10.1016/j.cell.2014.01.063.
9. Franchi L, Eigenbrod T, Muñoz-Planillo R, et al. Cytosolic double-stranded RNA activates the NLRP3 inflammasome via MAVS-induced membrane permeabilization and K+ efflux. J Immunol. 2014;193(8):4214–22. doi:10.4049/jimmunol.1400582.
10. Huang H, Saravia J, You D, Shaw AJ, Cormier SA. Impaired gamma delta T cell-derived IL-17A and inflammasome activation during early respiratory syncytial virus infection in infants. Immunol Cell Biol. 2014;. doi:10.1038/icb.2014.79.
11. Lupfer C, Malik A, Kanneganti T-D. Inflammasome control of viral infection. Curr Opin Virol. 2015;12:38–46. doi:10.1016/j.coviro.2015.02.007.
12. Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity. 2013;39(6):1003–18. doi:10.1016/j.immuni.2013.11.010.
13. Lopez-Castejon G, Brough D. Understanding the mechanism of IL-1beta secretion. Cytokine Growth Factor Rev. 2011;22(4):189–95. doi:10.1016/j.cytogfr.2011.10.001.
14. Rietdijk ST, Burwell T, Bertin J, Coyle AJ. Sensing intracellular pathogens-NOD-like receptors. Curr Opin Pharmacol. 2008;8(3):261–6. doi:10.1016/j.coph.2008.04.003.
15. Lamkanfi M, Kanneganti TD. Nlrp3: an immune sensor of cellular stress and infection. Int J Biochem Cell Biol. 2010;42(6):792–5. doi:10.1016/j.biocel.2010.01.008.
16. Hornung V, Ablasser A, Charrel-Dennis M, et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature. 2009;458(7237):514–8. doi:10.1038/nature07725.
17. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10(2):417–26.
18. Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014;157(5):1013–22. doi:10.1016/j.cell.2014.04.007.
19. Cridland JA, Curley EZ, Wykes MN, et al. The mammalian PYHIN gene family: phylogeny, evolution and expression. BMC Evol Biol. 2012;12(1):140. doi:10.1186/1471-2148-12-140.
20. Gram AM, Frenkel J, Ressing ME. Inflammasomes and viruses: cellular defence versus viral offence. J Gen Virol. 2012;93(Pt 10):2063–75. doi:10.1099/vir.0.042978-0.
21. Meylan E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature. 2006;442(7098):39–44. doi:10.1038/nature04946.
22. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. Nod-like proteins in immunity, inflammation and disease. Nat Immunol. 2006;7(12):1250–7. doi:10.1038/ni1412.
23. Werts C, Girardin SE, Philpott DJ. TIR, CARD and PYRIN: three domains for an antimicrobial triad. Cell Death Differ. 2006;13(5):798–815. doi:10.1038/sj.cdd.4401890.
24. Inohara N, Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol. 2003;3(5):371–82. doi:10.1038/nri1086.
25. Mariathasan S, Newton K, Monack DM, et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature. 2004;430(6996):213–8. doi:10.1038/nature02664.
26. Faustin B, Reed JC. Sunburned skin activates inflammasomes. Trends Cell Biol. 2008;18(1):4–8. doi:10.1016/j.tcb.2007.10.004.
27. Tattoli I, Travassos LH, Carneiro LA, Magalhaes JG, Girardin SE. The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation. Semin Immunopathol. 2007;29(3):289–301. doi:10.1007/s00281-007-0083-2.
28. Lu C, Wang A, Wang L, Dorsch M, Ocain TD, Xu Y. Nucleotide binding to CARD12 and its role in CARD12-mediated caspase-1 activation. Biochem Biophys Res Commun. 2005;331(4):1114–9. doi:10.1016/j.bbrc.2005.04.027.
29. Lupfer C, Kanneganti T-D. The expanding role of NLRs in antiviral immunity. Immunol Rev. 2013;255(1):13–24. doi:10.1111/imr.12089.
30. Gross O, Thomas CJ, Guarda G, Tschopp J. The inflammasome: an integrated view. Immunol Rev. 2011;243(1):136–51.
31. Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 2007;14(1):10–22. doi:10.1038/sj.cdd.4402038.
32. Bauernfeind FG, Horvath G, Stutz A, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 2009;183(2):787–91. doi:10.4049/jimmunol.0901363.
33. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol. 2009;27(1):229–65. doi:10.1146/annurev.immunol.021908.132715.
34. Hornung V, Bauernfeind F, Halle A, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008;9(8):847–56. doi:10.1038/ni.1631.
35. Cruz CM, Rinna A, Forman HJ, Ventura AL, Persechini PM, Ojcius DM. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem. 2007;282(5):2871–9. doi:10.1074/jbc.M608083200.
36. Kanneganti TD, Lamkanfi M, Kim YG, et al. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity. 2007;26(4):433–43. doi:10.1016/j.immuni.2007.03.008.
37. Murakami T, Ockinger J, Yu J, et al. Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc Natl Acad Sci USA. 2012;109(28):11282–7. doi:10.1073/pnas.1117765109.
38. Lee G-S, Subramanian N, Kim AI, et al. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature. 2012;492(7427):123–7. doi:10.1038/nature11588.
39. Feldmeyer L, Keller M, Niklaus G, Hohl D, Werner S, Beer HD. The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol. 2007;17(13):1140–5. doi:10.1016/j.cub.2007.05.074.
40. Triantafilou K, Hughes TR, Triantafilou M, Morgan BP. The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation. J Cell Sci. 2013;126(Pt 13):2903–13. doi:10.1242/jcs.124388.
41. Rossol M, Pierer M, Raulien N, et al. Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors. Nat Commun. 2012;3:1329.
42. Munoz-Planillo R, Kuffa P, Martinez-Colon G, Smith BL, Rajendiran TM, Nunez G. K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity. 2013;38(6):1142–53. doi:10.1016/j.immuni.2013.05.016.
43. Guo HC, Jin Y, Zhi XY, Yan D, Sun SQ. NLRP3 inflammasome activation by viroporins of animal viruses. Viruses. 2015;7(7):3380–91. doi:10.3390/v7072777.
44. Chen IY, Ichinohe T. Response of host inflammasomes to viral infection. Trends Microbiol. 2015;23(1):55–63. doi:10.1016/j.tim.2014.09.007.
45. Kanneganti TD, Body-Malapel M, Amer A, et al. Critical role for cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem. 2006;281(48):36560–8. doi:10.1074/jbc.M607594200.
46. Rajan JV, Rodriguez D, Miao EA, Aderem A. The NLRP3 inflammasome detects encephalomyocarditis virus and vesicular stomatitis virus infection. J Virol. 2011;85(9):4167–72. doi:10.1128/JVI.01687-10.
47. Ito M, Yanagi Y, Ichinohe T. Encephalomyocarditis virus viroporin 2B activates NLRP3 inflammasome. PLoS Pathog. 2012;8(8):e1002857. doi:10.1371/journal.ppat.1002857.
48. Komune N, Ichinohe T, Ito M, Yanagi Y. Measles virus V protein inhibits NLRP3 inflammasome-mediated interleukin-1 secretion. J Virol. 2011;85(24):13019–26. doi:10.1128/JVI.05942-11.
49. Triantafilou K, Kar S, Van Kuppeveld FJM, Triantafilou M. Rhinovirus-induced calcium flux triggers NLRP3 and NLRC5 activation in bronchial cells. Am J Respir Cell Mol Biol. 2013;49:923–34. doi:10.1165/rcmb.2013-0032OC.
50. Shrivastava S, Mukherjee A, Ray R, Ray RB. Hepatitis C virus induces interleukin-1 (IL-1)/IL-18 in circulatory and resident liver macrophages. J Virol. 2013;87(22):12284–90. doi:10.1128/JVI.01962-13.
51. Negash AA, Ramos HJ, Crochet N, et al. IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog. 2013;9(4):e1003330. doi:10.1371/journal.ppat.1003330.
52. Chen W, Xu Y, Li H, et al. HCV genomic RNA activates the NLRP3 inflammasome in human myeloid cells. PLoS ONE. 2014;9(1):e84953. doi:10.1371/journal.pone.0084953.
53. Owen DM, Gale M. Fighting the flu with inflammasome signaling. Immunity. 2009;30(4):476–8. doi:10.1016/j.immuni.2009.03.011.
54. Pang IK, Iwasaki A. Inflammasomes as mediators of immunity against influenza virus. Trends Immunol. 2011;32(1):34–41. doi:10.1016/j.it.2010.11.004.
55. Allen IC, Scull MA, Moore CB, et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity. 2009;30(4):556–65. doi:10.1016/j.immuni.2009.02.005.
56. Thomas PG, Dash P, Aldridge JR Jr, et al. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity. 2009;30(4):566–75. doi:10.1016/j.immuni.2009.02.006.
57. Ichinohe T, Pang IK, Iwasaki A. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat Immunol. 2010;11(5):404–10. doi:10.1038/ni.1861.
58. Segovia J, Sabbah A, Mgbemena V, et al. TLR2/MyD88/NF-kappaB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS ONE. 2012;7(1):e29695. doi:10.1371/journal.pone.0029695.
59. McAuley JL, Tate MD, MacKenzie-Kludas CJ, et al. Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease. PLoS Pathog. 2013;. doi:10.1371/journal.ppat.1003392.
60. Triantafilou K, Kar S, Vakakis E, Kotecha S, Triantafilou M. Human respiratory syncytial virus viroporin SH: a viral recognition pathway used by the host to signal inflammasome activation. Thorax. 2013;68(1):66–75. doi:10.1136/thoraxjnl-2012-202182.
61. Pontillo A, Silva LT, Oshiro TM, Finazzo C, Crovella S, Duarte AJS. HIV-1 induces NALP3-inflammasome expression and interleukin-1β secretion in dendritic cells from healthy individuals but not from HIV-positive patients. AIDS. 2012;26(1):11–8. doi:10.1097/QAD.0b013e32834d697f.
62. Ramos HJ, Lanteri MC, Blahnik G, et al. IL-1β signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathog. 2012;8(11):e1003039. doi:10.1371/journal.ppat.1003039.
63. Kumar M, Roe K, Orillo B, et al. Inflammasome adaptor protein Apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in west Nile virus encephalitis. J Virol. 2013;87(7):3655–67. doi:10.1128/JVI.02667-12.
64. Kaushik DK, Gupta M, Kumawat KL, Basu A. NLRP3 inflammasome: key mediator of neuroinflammation in murine Japanese encephalitis. PLoS ONE. 2012;7(2):e32270. doi:10.1371/journal.pone.0032270.
65. Hottz ED, Lopes JF, Freitas C, et al. Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood. 2013;122(20):3405–14. doi:10.1182/blood-2013-05-504449.
66. Wu M-F, Chen S-T, Yang A-H, et al. CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages. Blood. 2013;121(1):95–106. doi:10.1182/blood-2012-05-430090.
67. Ermler ME, Traylor Z, Patel K, et al. Rift valley fever virus infection induces activation of the NLRP3 inflammasome. Virology. 2014;449:174–80. doi:10.1016/j.virol.2013.11.015.
68. Wikan N, Khongwichit S, Phuklia W, et al. Comprehensive proteomic analysis of white blood cells from chikungunya fever patients of different severities. J Transl Med. 2014;12(1):96. doi:10.1186/1479-5876-12-96.
69. Muruve DA, Pétrilli V, Zaiss AK, et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature. 2008;452(7183):103–7. doi:10.1038/nature06664.
70. Delaloye J, Roger T, Steiner-Tardivel Q-G, et al. Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog. 2009;5(6):e1000480. doi:10.1371/journal.ppat.1000480.
71. Di Paolo NC, Miao EA, Iwakura Y, et al. Virus binding to a plasma membrane receptor triggers interleukin-1α-mediated proinflammatory macrophage response in vivo. Immunity. 2009;31(1):110–21. doi:10.1016/j.immuni.2009.04.015.
72. Barlan AU, Danthi P, Wiethoff CM. Lysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome. Virology. 2011;412(2):306–14. doi:10.1016/j.virol.2011.01.019.
73. Barlan AU, Griffin TM, McGuire KA, Wiethoff CM. Adenovirus membrane penetration activates the NLRP3 inflammasome. J Virol. 2011;85(1):146–55. doi:10.1128/JVI.01265-10.
74. Nour AM, Reichelt M, Ku C-C, Ho M-Y, Heineman TC, Arvin AM. Varicella-zoster virus infection triggers formation of an interleukin-1β (IL-1β)-processing inflammasome complex. J Biol Chem. 2011;286(20):17921–33. doi:10.1074/jbc.M110.210575.
75. Roberts TL, Idris A, Dunn JA, et al. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science. 2009;323(5917):1057–60. doi:10.1126/science.1169841.
76. Burckstummer T, Baumann C, Bluml S, et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol. 2009;10(3):266–72. doi:10.1038/ni.1702.
77. Rathinam VA, Jiang Z, Waggoner SN, et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol. 2010;11(5):395–402. doi:10.1038/ni.1864.
78. Ekchariyawat P, Hamel R, Bernard E, et al. Inflammasome signaling pathways exert antiviral effect against Chikungunya virus in human dermal fibroblasts. Infect Genet Evol. 2015;32:401–8. doi:10.1016/j.meegid.2015.03.025.
79. Hamel R, Dejarnac O, Wichit S, et al. Biology of Zika virus infection in human skin cells. J Virol. 2015;. doi:10.1128/JVI.00354-15.
80. Kawai T, Takahashi K, Sato S, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol. 2005;6(10):981–8. doi:10.1038/ni1243.
81. Rehwinkel J, Tan CP, Goubau D, et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell. 2010;140(3):397–408. doi:10.1016/j.cell.2010.01.020.
82. Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol. 2004;5(7):730–7. doi:10.1038/ni1087.
83. Kolakofsky D, Kowalinski E, Cusack S. A structure-based model of RIG-I activation. RNA. 2012;18(12):2118–27. doi:10.1261/rna.035949.112.
84. Hornung V, Ellegast J, Kim S, et al. 5′-Triphosphate RNA is the ligand for RIG-I. Science (80-). 2006;314(5801):994–7. doi:10.1126/science.1132505.
85. Kato H, Takeuchi O, Sato S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006;441(7089):101–5. doi:10.1038/nature04734.
86. Liu P, Jamaluddin M, Li K, Garofalo RP, Casola A, Brasier AR. Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J Virol. 2007;81(3):1401–11. doi:10.1128/JVI.01740-06.
87. Fredericksen BL, Gale M. West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J Virol. 2006;80(6):2913–23. doi:10.1128/JVI.80.6.2913-2923.2006.
88. Melchjorsen J, Jensen SB, Malmgaard L, et al. Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner. J Virol. 2005;79(20):12944–51. doi:10.1128/JVI.79.20.12944-12951.2005.
89. Mikkelsen SS, Jensen SB, Chiliveru S, et al. RIG-I-mediated activation of p38 MAPK is essential for viral induction of interferon and activation of dendritic cells. Dependence on TRAF2 and TAK1. J Biol Chem. 2009;284(16):10774–82. doi:10.1074/jbc.M807272200.
90. Pichlmair A, Schulz O, Tan CP, et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science (80-). 2006;314(5801):997–1001. doi:10.1126/science.1132998.
91. Rothenfusser S, Goutagny N, DiPerna G, et al. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J Immunol. 2005;175(8):5260–8. doi:10.4049/jimmunol.175.8.5260.
92. Fredericksen BL, Keller BC, Fornek J, Katze MG, Gale M. Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol. 2008;82(2):609–16. doi:10.1128/JVI.01305-07.
93. Chang TH, Liao CL, Lin YL. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3 K-dependent NF-κB activation. Microbes Infect. 2006;8:157–71. doi:10.1016/j.micinf.2005.06.014.
94. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature. 2008;454(July):523–7. doi:10.1038/nature07106.
95. Poeck H, Bscheider M, Gross O, et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol. 2010;11(1):63–9. doi:10.1038/ni.1824.
96. Benko S, Magalhaes JG, Philpott DJ, Girardin SE. NLRC5 limits the activation of inflammatory pathways. J Immunol. 2010;185(3):1681–91. doi:10.4049/jimmunol.0903900.
97. Cui J, Zhu L, Xia X, et al. NLRC5 Negatively regulates the NF-κB and type I interferon signaling pathways. Cell. 2010;141(3):483–96. doi:10.1016/j.cell.2010.03.040.
98. Kuenzel S, Till A, Winkler M, et al. The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses. J Immunol. 2010;184(4):1990–2000. doi:10.4049/jimmunol.0900557.
99. Meissner TB, Li A, Biswas A, et al. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc Natl Acad Sci USA. 2010;107(31):13794–9. doi:10.1073/pnas.1008684107.
100. Neerincx A, Lautz K, Menning M, et al. A role for the human NLR family member NLRC5 in antiviral responses. J Biol Chem. 2010;285(34):26223–32. doi:10.1074/jbc.M110.109736.
101. Davis BK, Roberts RA, Huang MT, et al. Cutting edge: NLRC5-dependent activation of the inflammasome. J Immunol. 2011;186(3):1333–7. doi:10.4049/jimmunol.1003111.
102. Moore CB, Bergstralh DT, Duncan JA, et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature. 2008;451(7178):573–7.
103. Tattoli I, Carneiro LA, Jéhanno M, et al. NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-κB and JNK pathways by inducing reactive oxygen species production. EMBO Rep. 2008;9:293–300. doi:10.1038/sj.embor.7401161.
104. Arnoult D, Soares F, Tattoli I, Castanier C, Philpott DJ, Girardin SE. An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix. J Cell Sci. 2009;122(Pt 17):3161–8.
105. Lei Y, Wen H, Yu Y, et al. The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy. Immunity. 2012;36(6):933–46.
106. Lei Y, Wen H, Ting JPY. The NLR protein, NLRX1, and its partner, TUFM, reduce type I interferon, and enhance autophagy. Autophagy. 2013;9(3):432–3.
107. Jaworska J, Coulombe F, Downey J, et al. NLRX1 prevents mitochondrial induced apoptosis and enhances macrophage antiviral immunity by interacting with influenza virus PB1-F2 protein. Proc Natl Acad Sci USA. 2014;. doi:10.1073/pnas.0507681102.
108. Unger BL, Ganesan S, Comstock AT, Faris AN, Hershenson MB, Sajjan US. Nod-like receptor X-1 is required for rhinovirus-induced barrier dysfunction in airway epithelial cells. J Virol. 2014;88(7):3705–3718. http://www.ncbi.nlm.nih.gov/pubmed/24429360.
109. Guo H, König R, Deng M, et al. NLRX1 sequesters STING to negatively regulate the interferon response, thereby facilitating the replication of HIV-1 and DNA viruses. Cell Host Microbe. 2016;19(4):515–28.
110. Jorgensen I, Miao EA. Pyroptotic cell death defends against intracellular pathogens. Immunol Rev. 2015;265(1):130–42. doi:10.1111/imr.12287.
111. Fink SL, Cookson BT. Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol. 2006;8(11):1812–25.
112. Denes A, Lopez-Castejon G, Brough D. Caspase-1: is IL-1 just the tip of the ICEberg? Cell Death Dis. 2012;3(7):e338. doi:10.1038/cddis.2012.86.
113. Miao EA, Rajan JV, Aderem A. Caspase-1-induced pyroptotic cell death. Immunol Rev. 2011;243(1):206–14. doi:10.1111/j.1600-065X.2011.01044.x.
114. Asgari E, Le Friec G, Yamamoto H, et al. C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. Blood. 2013;122(20):3473–81. doi:10.1182/blood-2013-05-502229.
115. de Gassart A, Martinon F. Pyroptosis: caspase-11 unlocks the gates of death. Immunity. 2015;43(5):835–7.
116. Yang D, He Y, Muñoz-Planillo R, Liu Q, Núñez G. Caspase-11 requires the pannexin-1 channel and the purinergic P2X7 pore to mediate pyroptosis and endotoxic shock. Immunity. 2015;. doi:10.1016/j.immuni.2015.10.009.
117. Chekeni FB, Elliott MR, Sandilos JK, et al. Pannexin 1 channels mediate “find-me” signal release and membrane permeability during apoptosis. Nature. 2010;467(7317):863–867. http://www.nature.com.iclibezp1.cc.ic.ac.uk/nature/journal/v467/n7317/full/nature09413.html.
118. Lu A, Magupalli VG, Ruan J, et al. Unified polymerization mechanism for the assembly of asc-dependent inflammasomes. Cell. 2014;156(6):1193–206. doi:10.1016/j.cell.2014.02.008.
119. Lu A, Wu H. Structural mechanisms of inflammasome assembly. FEBS J. 2015;282(3):435–44. doi:10.1111/febs.13133.
120. Le HT, Harton JA. Pyrin- and CARD-only proteins as regulators of NLR functions. Front Immunol. 2013;4:275. doi:10.3389/fimmu.2013.00275.
121. Stehlik C, Fiorentino L, Dorfleutner A, et al. The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor B activation pathways. J Exp Med. 2002;196(12):1605–15. doi:10.1084/jem.20021552.
122. Bedoya F, Sandler LL, Harton JA. Pyrin-only protein 2 modulates NF-κB and disrupts ASC: CLR interactions. J Immunol. 2007;178(6):3837–45. doi:10.4049/jimmunol.178.6.3837.
123. Atianand MK, Harton JA. Uncoupling of pyrin-only protein 2 (POP2)-mediated dual regulation of NF-κB and the inflammasome. J Biol Chem. 2011;286(47):40536–47. doi:10.1074/jbc.M111.274290.
124. Zamoshnikova A, Groß CJ, Schuster S, et al. NLRP12 is a neutrophil-specific, negative regulator of in vitro cell migration but does not modulate LPS- or infection-induced NF-κB or ERK signalling. Immunobiology. 2016;221(2):341–6. doi:10.1016/j.imbio.2015.10.001.
125. Khare S, Ratsimandresy RA, de Almeida L, et al. The PYRIN domain-only protein POP3 inhibits ALR inflammasomes and regulates responses to infection with DNA viruses. Nat Immunol. 2014;15(4):343–353. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4123781&tool=pmcentrez&rendertype=abstract.
126. Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. doi:10.1038/nri3452.
127. Devasthanam AS. Mechanisms underlying the inhibition of interferon signaling by viruses. Virulence. 2014;5(2):270–7. doi:10.4161/viru.27902.
128. Gan CS, Yusof R, Othman S. Different serotypes of dengue viruses differently regulate the expression of the host cell antigen processing machinery. Acta Trop. 2015;149:8–14. doi:10.1016/j.actatropica.2015.05.005.
129. Yang Q, Fu S, Wang J. Hepatitis C virus infection decreases the expression of Toll-like receptors 3 and 7 via upregulation of miR-758. Arch Virol. 2014. doi:10.1007/s00705-014-2167-3.
130. Karim R, Meyers C, Backendorf C, et al. Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes. PLoS ONE. 2011;6(3):e17848. doi:10.1371/journal.pone.0017848.
131. Niebler M, Qian X, Höfler D, et al. Post-translational control of IL-1b via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53. PLoS Pathog. 2013;9(8):e1003536. doi:10.1371/journal.ppat.1003536.
132. Radko S, Koleva M, James KMD, Jung R, Mymryk JS, Pelka P. Adenovirus E1A targets the DREF nuclear factor to regulate virus gene expression, DNA replication, and growth. J Virol. 2014;88(22):13469–81. doi:10.1128/JVI.02538-14.
133. Wulan WN, Heydet D, Walker EJ, Gahan ME, Ghildyal R. Nucleocytoplasmic transport of nucleocapsid proteins of enveloped RNA viruses. Front Microbiol. 2015;6:1–10. doi:10.3389/fmicb.2015.00553.
134. Rowe M, Glaunsinger B, van Leeuwen D, et al. Host shutoff during productive Epstein–Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proc Natl Acad Sci USA. 2007;104(9):3366–71. doi:10.1073/pnas.0611128104.
135. Tycowski KT, Guo YE, Lee N, et al. Viral noncoding RNAs: more surprises. Genes Dev. 2015;29(6):567–84. doi:10.1101/gad.259077.115.
136. Haneklaus M, Gerlic M, Kurowska-Stolarska M, et al. Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1 production. J Immunol. 2012;189(8):3795–9. doi:10.4049/jimmunol.1200312.
137. Lupfer CR, Kanneganti T-D. The role of inflammasome modulation in virulence. Virulence. 2012;3(3):262–70. doi:10.4161/viru.20266.
138. Marshall B, Puthalakath H, Caria S, et al. Variola virus F1L is a Bcl-2-like protein that unlike its vaccinia virus counterpart inhibits apoptosis independent of Bim. Cell Death Dis. 2015;6(3):e1680. doi:10.1038/cddis.2015.52.
139. Gerlic M, Faustin B, Postigo A, et al. Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation. Proc Natl Acad Sci USA. 2013;110(19):7808–13. doi:10.1073/pnas.1215995110.
140. Gregory SM, Davis BK, West JA, et al. Discovery of a viral NLR homolog that inhibits the inflammasome. Science (80-). 2011;331(6015):330–4. doi:10.1126/science.1199478.
141. Johnston JB, Barrett JW, Nazarian SH, et al. A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. Immunity. 2005;23(6):587–98. doi:10.1016/j.immuni.2005.10.003.
142. Wang D, Fang L, Wei D, et al. Hepatitis A virus 3C protease cleaves NEMO to impair induction of beta interferon. J Virol. 2014;88(17):10252–8. doi:10.1128/JVI.00869-14.
143. Wang H, Lei X, Xiao X, et al. Reciprocal regulation between enterovirus 71 and the NLRP3 inflammasome. Cell Rep. 2015;12(1):1–7. doi:10.1016/j.celrep.2015.05.047.
144. Ray CA, Black RA, Kronheim SR, et al. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell. 1992;69(4):597–604. doi:10.1016/0092-8674(92)90223-Y.
145. Petit F, Bertagnoli S, Gelfi J, Fassy F, Boucraut-Baralon C, Milon A. Characterization of a myxoma virus-encoded serpin-like protein with activity against interleukin-1 beta-converting enzyme. J Virol. 1996;70(9):5860–5866. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8709205\nhttp://jvi.asm.org/content/70/9/5860.full.pdf.
146. Kettle S, Alcamí A, Khanna A, Ehret R, Jassoy C, Smith GL. Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever. J Gen Virol. 1997;78(Pt 3):677–85.
147. Stasakova J. Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1 and 18. J Gen Virol. 2005;86(1):185–95. doi:10.1099/vir.0.80422-0.
148. Cheong W-C, Kang H-R, Yoon H, Kang S-J, Ting JP-Y, Song MJ. Influenza A virus NS1 protein inhibits the NLRP3 inflammasome. PLoS ONE. 2015;10(5):e0126456. doi:10.1371/journal.pone.0126456.